CVS shares pop 15% on big earnings beat, even as high medical costs drag down insurance unit

Louis Velazquez

Main PageFebruary 12, 2025

It caps off the first full quarter with David Joyner, a longtime CVS executive, as CEO of the troubled retail drugstore chain.

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Manage consent